What women want from their oral contraceptives

References

• Oddens BJ. Women’s satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception59(5), 277–286 (1999).
   PubMed Web of Science ®Google Scholar
• Glasier AF, Smith KB, van der Spuy ZM et al. Amenorrhea associated with contraception – an international study on acceptability. Contraception67, 1–8 (2003).
   PubMed Web of Science ®Google Scholar
• Ferrero S, Abbamonte LH, Giordano M et al. What is the desired menstrual frequency of women without menstruation-related symptoms? Contraception73, 537–541 (2006).
   PubMed Web of Science ®Google Scholar
• Morrison LA, Larkspur L, Calibuso MJ, Brown S. Women’s attitudes about menstruation and associated health and behavioral characteristics. Am. J. Health Behav.34(1), 90–100 (2010).
   PubMed Web of Science ®Google Scholar
• den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception59, 357–362 (1999).
   PubMed Web of Science ®Google Scholar
• Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am. J. Obstet. Gynecol.186(6), 1142–1149 (2002).
   PubMed Web of Science ®Google Scholar
• Loudon NB, Foxwell M, Potts DM, Guild AL, Short RV. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen. Br. Med. J.2(6085), 487–490 (1977).
   PubMed Web of Science ®Google Scholar
• ARHP. Extended Regime Oral Contraceptive. Harris Poll, 14–17 (2002).
   Google Scholar
• Andrist LC, Hoyt A, Weinstein D, McGibbon C. The need to bleed: women’s attitudes and beliefs about menstrual suppression. J. Am. Acad. Nurse Pract.16(1), 31–37 (2004).
   PubMedGoogle Scholar
• Snowden R, Christian B. Patterns and Perceptions of Menstruation. St Martin’s Press, NY, USA (1983).
   Google Scholar
• Edelman A, Lew R, Cwiak C, Nichols M, Jensen J. Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women. Contraception75(6), 450–453 (2007).
   PubMed Web of Science ®Google Scholar
• Sánchez-Borrego R, García-Calvo C. Spanish women’s attitudes towards menstruation and use of a continuous, daily use hormonal combined contraceptive regimen. Contraception77(2), 114–117 (2008).
   PubMed Web of Science ®Google Scholar
• Edelman A, Gallo MF, Nichols MD, Jensen JT, Schulz KF, Grimes DA. Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials. Hum. Reprod.21(3), 573–578 (2006).
   PubMed Web of Science ®Google Scholar
• Egarter C, Topcuoglu MA, Imhof M, Huber J. Low dose oral contraceptives and quality of life. Contraception59(5), 287–291 (2006).
   Google Scholar
• Coffee AL, Sulak PJ, Kuehl TJ. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception75(6), 444–449 (2007).
   PubMed Web of Science ®Google Scholar
• Endrikat J, Müller U, Düsterberg B. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance. Contraception55(3), 131–137 (1997).
   PubMed Web of Science ®Google Scholar
• Poindexter AN, Burkman R, Fisher AC, LaGuardia KD. Cycle control, tolerability, and satisfaction among women switching from 30–35 microg ethinylestradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO. Int. J. Fertil. Womens Med.48(4), 163–172 (2003).
   PubMedGoogle Scholar
• Ernst U, Baumgartner L, Bauer U, Janssen G. Improvement of quality of life in women using a low-dose desogestrel-containing contraceptive: results of an observational clinical evaluation. Eur. J. Contracept. Reprod. Health Care7(4), 238–243 (2002).
   PubMed Web of Science ®Google Scholar
• Sulak P, Lippman J, Siu C, Massaro J, Godwin A. Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction. Contraception59(3), 161–166 (1999).
   PubMed Web of Science ®Google Scholar
• Moreau C, Cleland K, Trussell J. Contraceptive discontinuation attributed to method dissatisfaction in the United States. Contraception76(4), 267–272 (2007).
   PubMed Web of Science ®Google Scholar
• Colli E, Tong D, Penhallegon R, Parazzini F. Reasons for contraceptive discontinuation in women 20–39 years old in New Zealand. Contraception59(4), 227–231 (1999).
   PubMed Web of Science ®Google Scholar
• Murphy PA, Brixner D. Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database. Contraception77(4), 257–263 (2008).
   PubMed Web of Science ®Google Scholar
• Gilliam ML, Warden M, Goldstein C, Tapia B. Concerns about contraceptive side effects among young Latinas: a focus-group approach. Contraception70(4), 299–305 (2004).
   PubMed Web of Science ®Google Scholar
• den Tonkelaar I, Oddens BJ. Factors influencing women’s satisfaction with birth control methods. Eur. J. Contracept. Reprod. Health Care6(3), 153–158 (2001).
   PubMed Web of Science ®Google Scholar
• Sangi-Haghpeykar H, Ali N, Posner S, Poindexter AN. Disparities in contraceptive knowledge, attitude and use between Hispanic and non-Hispanic whites. Contraception74(2), 125–132 (2006).
   PubMed Web of Science ®Google Scholar
• Sear AM, Turner MN. Factors associated with short-term oral contraceptive discontinuation. Fam. Plann. Perspect.6(4), 230–233 (1974).
   PubMedGoogle Scholar
• From the Centers for Disease Control and Prevention. Ten great public health achievements – United States, 1900–1999. JAMA281(16), 1481 (1999).
   PubMed Web of Science ®Google Scholar
• Marks, Lara V. Sexual Chemistry: A History of the Contraceptive Pill. Yale University Press, New Haven, CT, USA (2001).
   Google Scholar
• Garcia CR, Pincus G, Rock J. Effects of certain 19-nor steroids on the normal human menstrual cycle. Science124(3227), 891–893 (1956).
   PubMed Web of Science ®Google Scholar
• Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am. J. Obstet. Gynecol.190(Suppl. 4), S5–S22 (2004).
   PubMed Web of Science ®Google Scholar
• Boonstra H, Duran V, Northington Gamble V, Blumenthal P, Dominguez L, Pies C. The ‘boom and bust phenomenon’: the hopes, dreams, and broken promises of the contraceptive revolution. Contraception61(1), 9–25 (2000).
   PubMed Web of Science ®Google Scholar
• Kaunitz AM. Oral contraceptive health benefits: perception versus reality. Contraception59(Suppl. 1), S29–S33 (1999).
   PubMed Web of Science ®Google Scholar
• Tessler SL, Peipert JF. Perceptions of contraceptive effectiveness and health effects of oral contraception. Womens Health Issues6, 400–406 (1997).
   Google Scholar
• Nelson AL, Rezvan A. A pilot study of women’s knowledge of pregnancy risks: implications for contraception. Contraception (2011) (In Press).
   PubMedGoogle Scholar
• Grisaru-Granovsky S, Gordon ES, Haklai Z, Samueloff A, Schimmel MM. Effect of interpregnancy interval on adverse perinatal outcomes – a national study. Contraception80(6), 512–518 (2009).
   PubMed Web of Science ®Google Scholar
• Tsui AO, McDonald-Mosley R, Burke AE. Family planning and the burden of unintended pregnancies. Epidemiol. Rev.32(1), 152–174 (2010).
   PubMed Web of Science ®Google Scholar
• Hladik W, Stover J, Esiru G, Harper M, Tappero J. The contribution of family planning towards the prevention of vertical HIV transmission in Uganda. PLoS One4(11), e7691 (2009).
   Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG Committee Opinion number 313, September 2005. The importance of preconception care in the continuum of women’s health care. Obstet. Gynecol.106(3), 665–666 (2005).
   PubMedGoogle Scholar
• Gipson JD, Koenig MA, Hindin MJ. The effects of unintended pregnancy on infant, child, and parental health: a review of the literature. Stud. Fam. Plann.39(1), 18–38 (2008).
   PubMed Web of Science ®Google Scholar
• Cleland J, Bernstein S, Ezeh A, Faundes A, Glasier A, Innis J. Family planning: the unfinished agenda. Lancet368(9549), 1810–1827 (2006).
   PubMed Web of Science ®Google Scholar
• Chuang CH, Velott DL, Weisman CS. Exploring knowledge and attitudes related to pregnancy and preconception health in women with chronic medical conditions. Matern. Child Health J.14(5), 713–719 (2010).
   PubMed Web of Science ®Google Scholar
• Stover J, Ross J. How increased contraceptive use has reduced maternal mortality. Matern. Child Health J.14(5), 687–695 (2010).
   PubMed Web of Science ®Google Scholar
• Winikoff B, Sullivan M. Assessing the role of family planning in reducing maternal mortality. Stud. Fam. Plann.18(3), 128–143 (1987).
   PubMed Web of Science ®Google Scholar
• Moos MK, Petersen R, Meadows K, Melvin CL, Spitz AM. Pregnant women’s perspectives on intendedness of pregnancy. Womens Health Issues7(6), 385–392 (1997).
   PubMed Web of Science ®Google Scholar
• Bruckner H, Martin A, Bearman PS. Ambivalence and pregnancy: adolescents’ attitudes, contraceptive use and pregnancy. Perspect. Sex Reprod. Health36(6), 248–257 (2004).
   PubMed Web of Science ®Google Scholar
• Kendall C, Afable-Munsuz A, Speizer I, Avery A, Schmidt N, Santelli J. Understanding pregnancy in a population of inner-city women in New Orleans – results of qualitative research. Soc. Sci. Med.60(2), 297–311 (2005).
   PubMed Web of Science ®Google Scholar
• Luker KC. A reminder that human behavior frequently refuses to conform to models created by researchers. Fam. Plann. Perspect.31(5), 248–249 (1999).
   PubMedGoogle Scholar
• Miller WB. Why some women fail to use their contraceptive method: a psychological investigation. Fam. Plann. Perspect.18(1), 27–32 (1986).
   PubMedGoogle Scholar
• Shorto R. Contra Contraception. New York Times Magazine, May 7 (2006).
   Google Scholar
• Silverman J, Torres A, Forrest JD. Barriers to contraceptive services. Fam. Plann. Perspect.19(3), 94–97, 101–102 (1987).
   PubMedGoogle Scholar
• Nettleman MD, Brewer J, Ayoola A. Why women risk unintended pregnancy. J. Fam. Pract.58(4), E1–E5 (2009).
   PubMedGoogle Scholar
• Paterson J, Tumama Cowley E, Percival T, Williams M. Pregnancy planning by mothers of Pacific infants recently delivered at Middlemore Hospital. NZ Med. J.117(1188), U744 (2004).
   Google Scholar
• Jewell D, Tacchi J, Donovan J. Teenage pregnancy: whose problem is it? Fam. Pract.17(6), 522–528 (2000).
   PubMed Web of Science ®Google Scholar
• Foster DG, Biggs MA, Amaral G et al. Estimates of pregnancies averted through California’s family planning waiver program in 2002. Perspect. Sex Reprod. Health38(3), 126–131 (2006).
   PubMedGoogle Scholar
• Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982–2002. Adv. Data.10(350), 1–36 (2004).
   Google Scholar
• Mosher WD, Jones J. Use of contraception in the United States: 1982–2008. National Center for Health Statistics. Vital. Health Stat.23(29), 1–44 (2010).
   Google Scholar
• Blackburn RD, Cunkelman A, Zlidar VM. Oral contraceptives – an update. Popul. Rep. A.28(1), 1–16, 25–32 (2000).
   Google Scholar
• Nelson AL, Westhoff C, Schnare SM. Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuation. Obstet. Gynecol.112(4), 782–787 (2008).
   PubMed Web of Science ®Google Scholar
• Halpern V, Grimes DA, Lopez L, Gallo MF. Strategies to improve adherence and acceptability of hormonal methods for contraception. Cochrane Database Syst. Rev.1, CD004317 (2006).
   Google Scholar
• Isley MM, Edelman A, Kaneshiro B, Peters D, Nichols MD, Jensen JT. Sex education and contraceptive use at coital debut in the United States: results from Cycle 6 of the National Survey of Family Growth. Contraception82(3), 236–242 (2010).
   PubMedGoogle Scholar
• Rajasekar D, Bigrigg A, Docherty G. Nationwide audit of pill knowledge amongst family planning users in Scotland. Eur. J. Contracept. Reprod. Health Care4(2), 95–102 (1999).
   PubMedGoogle Scholar
• Morgan SP, Rackin H. The Correspondence Between Fertility Intentions and Behavior in the United States. Popul. Dev. Rev.36(1), 91–118 (2010).
   PubMed Web of Science ®Google Scholar
• Kost K, Singh S, Vaughan B, Trussell J, Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception77(1), 10–21 (2008).
   PubMed Web of Science ®Google Scholar
• Frost JJ, Singh S, Finer LB. Factors associated with contraceptive use and nonuse, United States, 2004. Perspect. Sex Reprod. Health39(2), 90–99 (2007).
   PubMed Web of Science ®Google Scholar
• Burke AE, Blumenthal PD. Successful use of oral contraceptives. Semin. Reprod. Med.19(4), 313–321 (2001).
   PubMedGoogle Scholar
• Westhoff CL, Heartwell S, Edwards S et al. Oral contraceptive discontinuation: do side effects matter? Am. J. Obstet. Gynecol.196(4), 412.e1–e6 (2007).
   PubMed Web of Science ®Google Scholar
• Nelson AL, Pietersz D, Nelson LE, Aguilera L. Documented short-term continuation rates for combined hormonal contraceptives in an indigent population with ready access to contraceptive supplies. Am. J. Obstet. Gynecol.196(6), 599.e1–e5 (2007).
   Google Scholar
• Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am. J. Obstet. Gynecol.179(3 Pt 1), 577–582 (1998).
   PubMed Web of Science ®Google Scholar
• Westhoff C, Heartwell S, Edwards S et al. Initiation of oral contraceptives using a quick start compared with a conventional start: a randomized controlled trial. Obstet. Gynecol.109(6), 1270–1276 (2007).
   PubMed Web of Science ®Google Scholar
• Frost JJ, Singh S, Finer LB. U.S. women’s one-year contraceptive use patterns, 2004. Perspect. Sex Reprod. Health39(1), 48–55 (2007).
   PubMed Web of Science ®Google Scholar
• Rosenberg M, Waugh MS. Causes and consequences of oral contraceptive noncompliance. Am. J. Obstet. Gynecol.180(2 Pt 2), 276–279 (1999).
   PubMed Web of Science ®Google Scholar
• Potter L, Oakley D, de Leon-Wong E, Cañamar R. Measuring compliance among oral contraceptive users. Fam. Plann. Perspect.28(4), 154–158 (1996).
   PubMedGoogle Scholar
• Rosenberg MJ, Waugh MS, Long S. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. J. Reprod. Med.40(5), 355–360 (1995).
   PubMed Web of Science ®Google Scholar
• Creinin MD, Lippman JS, Eder SE, Godwin AJ, Olson W. The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol. Contraception66(3), 147–152 (2002).
   PubMed Web of Science ®Google Scholar
• Korver T, Goorissen E, Guillebaud J. The combined oral contraceptive pill: what advice should we give when tablets are missed? Br. J. Obstet. Gynaecol.102(8), 601–607 (1995).
   PubMedGoogle Scholar
• Thorneycroft IH. Cycle control with oral contraceptives: a review of the literature. Am. J. Obstet. Gynecol.180(2 Pt 2), 280–287 (1999).
   PubMedGoogle Scholar
• Eisenberg ME, Bearinger LH, Sieving RE, Swain C, Resnick MD. Parents’ beliefs about condoms and oral contraceptives: are they medically accurate? Perspect. Sex Reprod. Health36(2), 50–57 (2004).
   PubMed Web of Science ®Google Scholar
• Foster DG, Parvataneni R, de Bocanegra HT, Lewis C, Bradsberry M, Darney P. Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet. Gynecol.108(5), 1107–1114 (2006).
   PubMed Web of Science ®Google Scholar
• Foster DG, Hulett D, Bradsberry M, Darney P, Policar M. Number of oral contraceptive pill packages dispensed and subsequent unintended pregnancies. Obstet. Gynecol.117(3), 566–572 (2011).
   PubMed Web of Science ®Google Scholar
• Vessey M, Painter R, Yeates D. Mortality in relation to oral contraceptive use and cigarette smoking. Lancet362(9379), 185–191 (2003).
   PubMed Web of Science ®Google Scholar
• Peipert JF, Gutmann J. Oral contraceptive risk assessment, a survey of 247 educated women. Obstet. Gynecol.82(1), 112–117 (1993).
   PubMed Web of Science ®Google Scholar
• Deijen JB, Kornaat H. The influence of type of information, somatization, and locus of control on attitude, knowledge, and compliance with respect to the triphasic oral contraceptive Tri-Minulet. Contraception56(1), 31–41 (1997).
   PubMed Web of Science ®Google Scholar
• Picardo CM, Nichols M, Edelman A, Jensen JT. Women’s knowledge and sources of information on the risks and benefits of oral contraception. J. Am. Med. Womens Assoc.58(2), 112–116 (2003).
   PubMedGoogle Scholar
• Murphy P, Kirkman A, Hale RW. A national survey of women’s attitudes toward oral contraception and other forms of birth control. Womens Health Issues5(2), 94–99 (1995).
   PubMedGoogle Scholar
• Grossman D, Fernández L, Hopkins K, Amastae J, Potter JE. Perceptions of the safety of oral contraceptives among a predominantly Latina population in Texas. Contraception81(3), 254–260 (2010).
   PubMed Web of Science ®Google Scholar
• Trussell J, Jordan B. Reproductive health risks in perspective. Contraception73(5), 437–439 (2006).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). U S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Recomm. Rep.59(RR–4), 1–86 (2010).
   PubMedGoogle Scholar
• Porter JB, Jick H, Walker AM. Mortality among oral contraceptive users. Obstet. Gynecol.70(1), 29–32 (1987).
   PubMed Web of Science ®Google Scholar
• Williamson LM, Buston K, Sweeting H. Young women’s perceptions of pregnancy risk and use of emergency contraception: findings from a qualitative study. Contraception79(4), 310–315 (2009).
   PubMed Web of Science ®Google Scholar
• WHO. Trends in Maternal Mortality: 1990 to 2008 Estimates developed by WHO, UNICEF, UNFPA and The World Bank. WHO Press, Geneva, Switzerland (2010).
   Google Scholar
• Kuklina EV, Meikle SF, Jamieson DJ et al. Severe obstetric morbidity in the United States: 1998–2005. Obstet. Gynecol.113(2 Pt 1), 293–299 (2009).
   PubMed Web of Science ®Google Scholar
• UNICEF. Progress For Children: A Report Card on Maternal Mortality Number 7. UNICEF Division of Communication, NY, USA (2008).
   Google Scholar
• Guillebaud J. The pill at 40 – a new look at a familiar method. Will the pill become obsolete in this century? Fam. Plann. Perspect.32(2), 93–94 (2000).
   PubMedGoogle Scholar
• Tydén T, Bingefors K, Odlind V. Oral contraceptives and compliance: reaction to cardiovascular alarm among users. Adv. Contracept.15(2), 133–139 (1999).
   PubMedGoogle Scholar
• Szarewski A, Mansour D. The ‘pill scare’: the responses of authorities, doctors and patients using oral contraception. Hum. Reprod. Update.5(6), 627–632 (1999).
   PubMedGoogle Scholar
• Farmer RD, Williams TJ, Simpson EL, Nightingale AL. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database. BMJ321(7259), 477–479 (2000).
   PubMed Web of Science ®Google Scholar
• Spitzer WO. The 1995 pill scare revisited: anatomy of a non-epidemic. Hum. Reprod.12(11), 2347–2357 (1997).
   PubMed Web of Science ®Google Scholar
• Dinger JC, Heinemann LA, Kühl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception75(5), 344–354 (2007).
   PubMed Web of Science ®Google Scholar
• Cheung E, Free C. Factors influencing young women’s decision making regarding hormonal contraceptives: a qualitative study. Contraception71(6), 426–431 (2005).
   PubMed Web of Science ®Google Scholar
• Hannaford PC, Iversen L, Macfarlane TV, Elliott AM, Angus V, Lee AJ. Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study. BMJ340, c927 (2010).
   PubMed Web of Science ®Google Scholar
• Little P, Griffin S, Kelly J, Dickson N, Sadler C. Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial. BMJ316(7149), 1948–1952 (1998).
   PubMed Web of Science ®Google Scholar
• Fritsche MD, Ables AZ, Bendyk H. Opportunities missed: improving the rate of contraceptive counseliung or provision when prescribing reproductive-aged women potentially teratogenic medications in a family medicine resident clinic. Contraception (2011) (In Press).
   PubMedGoogle Scholar
• Cramer JA. Compliance with contraceptives and other treatments. Obstet. Gynecol.88(Suppl. 3), S4–S12 (1996).
   PubMed Web of Science ®Google Scholar
• Oakley D, Sereika S, Bogue EL. Oral contraceptive pill use after an initial visit to a family planning clinic. Fam. Plann. Perspect.23(4), 150–154 (1991).
   PubMedGoogle Scholar
• Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception51(5), 283–288 (1995).
   PubMed Web of Science ®Google Scholar
• Rosenberg MJ, Waugh MS, Burnhill MS. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation. Fam. Plann. Perspect.30(2), 89–92, 104 (1998).
   PubMedGoogle Scholar
• Smith JD, Oakley D. Why do women miss oral contraceptive pills? An analysis of women’s self-described reasons for missed pills. J. Midwifery Womens Health.50(5), 380–385 (2005).
   PubMed Web of Science ®Google Scholar
• Letterie GS, Chow GE. Effect of ‘missed’ pills on oral contraceptive effectiveness. Obstet. Gynecol.79(6), 979–982 (1992).
   PubMed Web of Science ®Google Scholar
• Lete I, Doval JL, Pérez-Campos E et al. Self-described impact of noncompliance among users of a combined hormonal contraceptive method. Contraception77(4), 276–282 (2008).
   PubMed Web of Science ®Google Scholar
• Moreau C, Bouyer J, Gilbert F, Group C, Bajos N. Social, demographic and situational characteristics associated with inconsistent use of oral contraceptives: evidence from France. Perspect. Sex Reprod. Health38(4), 190–196 (2006).
   PubMed Web of Science ®Google Scholar
• Mansour D. Revision of the ‘missed pill’ rules. J. Fam. Plann. Reprod. Health Care (2011) (In Press).
   Google Scholar
• Vaughan B, Trussell J, Kost K, Singh S, Jones R. Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth. Contraception78(4), 271–283 (2008).
   PubMed Web of Science ®Google Scholar
• Westhoff C, Jones K, Robilotto C et al. Smoking and oral contraceptive continuation. Contraception79(5), 375–378 (2009).
   PubMed Web of Science ®Google Scholar
• Sable MR, Libbus MK, Chiu JE. Factors affecting contraceptive use in women seeking pregnancy tests: Missouri, 1997. Fam. Plann. Perspect.32(3), 124–131 (2000).
   PubMedGoogle Scholar
• Sable MR, Libbus MK. Beliefs concerning contraceptive acquisition and use among low-income women. J. Health Care Poor Underserved.9(3), 262–275 (1998).
   PubMed Web of Science ®Google Scholar
• Lachowsky M, Levy-Toledano R. Improving compliance in oral contraception: ‘the reminder card’. Eur. J. Contracept. Reprod. Health Care7(4), 210–215 (2002).
   PubMed Web of Science ®Google Scholar
• Matter S, Meier B. Prospective memory affects satisfaction with the contraceptive pill. Contraception78(2), 120–124 (2008).
   PubMedGoogle Scholar
• Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA285(17), 2232–2239 (2001).
   PubMed Web of Science ®Google Scholar
• Harper C, Balistreri E, Boggess J, Leon K, Darney P. Provision of hormonal contraceptives without a mandatory pelvic examination: the first stop demonstration project. Fam. Plann. Perspect.33(1), 13–18 (2001).
   PubMedGoogle Scholar
• Lara-Torre E, Schroeder B. Adolescent compliance and side effects with Quick Start initiation of oral contraceptive pills. Contraception66(2), 81–85 (2002).
   PubMed Web of Science ®Google Scholar
• Westhoff C, Morroni C, Kerns J, Murphy PA. Bleeding patterns after immediate vs. conventional oral contraceptive initiation: a randomized, controlled trial. Fertil. Steril.79(2), 322–329 (2003).
   PubMedGoogle Scholar
• Lopez LM, Newmann SJ, Grimes DA, Nanda K, Schulz KF. Immediate start of hormonal contraceptives for contraception. Cochrane Database Syst. Rev.2, CD006260 (2008).
   Google Scholar
• Westhoff C, Kerns J, Morroni C, Cushman LF, Tiezzi L, Murphy PA. Quick start: novel oral contraceptive initiation method. Contraception66(3), 141–145 (2002).
   PubMed Web of Science ®Google Scholar
• Schafer JE, Osborne LM, Davis AR, Westhoff C. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive. Contraception73(5), 488–492 (2006).
   PubMed Web of Science ®Google Scholar
• Cronin M, Schellschmidt I, Dinger J. Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives. Obstet. Gynecol.114(3), 616–622 (2009).
   PubMed Web of Science ®Google Scholar
• Kane R, Irving G, Brown S, Parkes N, Walling M, Killick S. Long-acting, reversible and permanent methods of contraception: insight into women’s choice of method. Qual. Prim. Care17(2), 107–114 (2009).
   PubMedGoogle Scholar
• Nappi RE, Albani F, Tonani S et al. Psychosexual well-being in women using oral contraceptives containing drospirenone. Funct. Neurol.24(2), 71–75 (2009).
   PubMed Web of Science ®Google Scholar
• Rosenfield JA, Everett K. Lifetime patterns of contraception and their relationship to unintended pregnancies. J. Fam. Pract.49(9), 823–828 (2000).
   PubMedGoogle Scholar
• Metson D. Lessons from an audit of unplanned pregnancies. BMJ297(6653), 904–906 (1988).
   PubMedGoogle Scholar
• Clark LR. Will the pill make me sterile? Addressing reproductive health concerns and strategies to improve adherence to hormonal contraceptive regimens in adolescent girls. J. Pediatr. Adolesc. Gynecol.14(4), 153–162 (2001).
   PubMedGoogle Scholar
• Ayoola AB, Nettleman M, Brewer J. Reasons for unprotected intercourse in adult women. J. Womens Health (Larchmt)16(3), 302–310 (2007).
   PubMed Web of Science ®Google Scholar
• Graesslin O, Barjot P, Hoffet M, Cohen D, Vaillant P, Clerson P. The EVAPIL scale, a new tool to assess tolerance of oral contraceptives. Contraception80(6), 540–554 (2009).
   PubMedGoogle Scholar
• Trussell J, Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Fam. Plann. Perspect.31(2), 64–72 (1999).
   PubMedGoogle Scholar
• Kalmuss D, Koenemann S, Westhoff C et al. Prior pill experiences and current continuation among pill restarters. Perspect. Sex Reprod. Health40(3), 138–143 (2008).
   PubMedGoogle Scholar
• Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ. Hormone withdrawal symptoms in oral contraceptive users. Obstet. Gynecol.95(2), 261–266 (2000).
   PubMed Web of Science ®Google Scholar
• Davis A, Wysocki S. Clinician/patient interaction: communicating the benefits and risks of oral contraceptives. Contraception59(Suppl. 1), S39–S42 (1999).
   PubMed Web of Science ®Google Scholar
• Herold ES, Goodwin MS. Perceived side effects of oral contraceptives among adolescent girls. Can. Med. Assoc J.123(10), 1022–1026 (1980).
   PubMed Web of Science ®Google Scholar
• Coney P, Washenik K, Langley RG, DiGiovanna JJ, Harrison DD. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception63(6), 297–302 (2001).
   PubMed Web of Science ®Google Scholar
• Gallo MF, Lopez LM, Grimes DA, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst. Rev.4, CD003987 (2008).
   Google Scholar
• O’Connell KJ, Osborne LM, Westhoff C. Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive. Contraception72(5), 323–327 (2005).
   PubMed Web of Science ®Google Scholar
• Loder EW, Buse DC, Golub JR. Headache as a side effect of combination estrogen–progestin oral contraceptives: a systematic review. Am. J. Obstet. Gynecol.193(3 Pt 1), 636–649 (2005).
   PubMed Web of Science ®Google Scholar
• Higgins JA, Hoffman S, Graham CA, Sanders SA. Relationships between condoms, hormonal methods, and sexual pleasure and satisfaction: an exploratory analysis from the Women’s Well-Being and Sexuality Study. Sex. Health5(4), 321–330 (2008).
   PubMed Web of Science ®Google Scholar
• Davis AR, Castaño PM. Oral contraceptives and libido in women. Annu. Rev. Sex. Res.15, 297–320 (2004).
   PubMedGoogle Scholar
• Guida M, Di Spiezio Sardo A, Bramante S et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum. Reprod.20(4), 1100–1106 (2005).
   PubMed Web of Science ®Google Scholar
• Strufaldi R, Pompei LM, Steiner ML et al. Effects of two combined hormonal contraceptives with the same composition and different doses on female sexual function and plasma androgen levels. Contraception82(2), 147–154 (2010).
   PubMed Web of Science ®Google Scholar
• Coutinho EM, Segal SJ. Is Menstruation Obsolete? Oxford University Press, NY, USA (1999).
   Google Scholar
• Benagiano G, Carrara S, Filippi V. Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives. Patient Prefer. Adherence3, 131–143 (2009).
   PubMed Web of Science ®Google Scholar
• Clark LR, Barnes-Harper KT, Ginsburg KR, Holmes WC, Schwarz DF. Menstrual irregularity from hormonal contraception: a cause of reproductive health concerns in minority adolescent young women. Contraception74(3), 214–219 (2006).
   PubMed Web of Science ®Google Scholar
• Cheung E, Free C. Factors influencing young women’s decision making regarding hormonal contraceptives: a qualitative study. Contraception71(6), 426–431 (2005).
   PubMed Web of Science ®Google Scholar
• Gold MA, Coupey SM. Young women’s attitudes toward injectable and implantable contraceptives. J. Pediatr. Adolesc. Gynecol.11(1), 17–24 (1998).
   PubMedGoogle Scholar
• Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception. Cochrane Database Syst. Rev.1, CD003989 (2011).
   Google Scholar
• Bachmann G, Sulak PJ, Sampson-Landers C, Benda N, Marr J. Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone. Contraception70(3), 191–198 (2004).
   PubMed Web of Science ®Google Scholar
• Hampton RM, Fisher AC, Pagano S, LaGuardia KD. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization. Fertil. Steril.92(2), 434–440 (2009).
   PubMedGoogle Scholar
• Mishell DR Jr, Guillebaud J, Westhoff C et al. Combined hormonal contraceptive trials: variable data collection and bleeding assessment methodologies influence study outcomes and physician perception. Contraception75(1), 4–10 (2007).
   PubMed Web of Science ®Google Scholar
• Richter M, Eck J, Straube T, Miltner WH, Weiss T. Do words hurt? Brain activation during the processing of pain-related words. Pain148(2), 198–205 (2010).
   PubMed Web of Science ®Google Scholar
• Vitzthum VJ, Ringheim K. Hormonal contraception and physiology: a research-based theory of discontinuation due to side effects. Stud. Fam. Plann.36(1), 13–32 (2005).
   PubMed Web of Science ®Google Scholar
• Goldzieher JW, Moses LE, Averkin E, Scheel C, Taber BZ. A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives. Fertil. Steril.22(9), 609–623 (1971).
   PubMed Web of Science ®Google Scholar
• Redmond G, Godwin AJ, Olson W, Lippman JS. Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence. Contraception60(2), 81–85 (1999).
   PubMed Web of Science ®Google Scholar
• Maloney JM, Dietze P Jr, Watson D et al. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial. Obstet. Gynecol.112(4), 773–781 (2008).
   PubMed Web of Science ®Google Scholar
• Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception72(6), 414–421 (2005).
   PubMed Web of Science ®Google Scholar
• O’Connell K, Davis AR, Kerns J. Oral contraceptives, side effects and depression in adolescent girls. Contraception75(4), 299–304 (2007).
   PubMed Web of Science ®Google Scholar
• Grimes DA, Schulz KF. Nonspecific side effects of oral contraceptives: nocebo or noise? Contraception83(1), 5–9 (2011).
   PubMed Web of Science ®Google Scholar
• Culwell KR, Feinglass J. The association of health insurance with use of prescription contraceptives. Perspect. Sex Reprod. Health39(4), 226–230 (2007).
   PubMed Web of Science ®Google Scholar
• Postlethwaite D, Trussell J, Zoolakis A, Shabear R, Petitti D. A comparison of contraceptive procurement pre- and post-benefit change. Contraception76(5), 360–365 (2007).
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet. Gynecol.106(3), 492–501 (2005).
   PubMed Web of Science ®Google Scholar
• Gaudet LM, Kives S, Hahn PM, Reid RL. What women believe about oral contraceptives and the effect of counseling. Contraception69(1), 31–36 (2004).
   PubMed Web of Science ®Google Scholar
• Vessey MP, Painter R. Endometrial and ovarian cancer and oral contraceptives – findings in a large cohort study. Br. J. Cancer71(6), 1340–1342 (1995).
   PubMed Web of Science ®Google Scholar
• Schlesselman JJ. Oral contraceptives and neoplasia of the uterine corpus. Contraception43(6), 557–579 (1991).
   PubMed Web of Science ®Google Scholar
• Sanderson M, Williams MA, Weiss NS, Hendrix NW, Chauhan SP. Oral contraceptives and epithelial ovarian cancer. Does dose matter? J. Reprod. Med.45(9), 720–726 (2000).
   PubMed Web of Science ®Google Scholar
• Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. JAMA257(6), 796–800 (1987).
   PubMed Web of Science ®Google Scholar
• Jick SS, Walker AM, Jick H. Oral contraceptives and endometrial cancer. Obstet. Gynecol.82(6), 931–935 (1993).
   PubMed Web of Science ®Google Scholar
• de Abood M, de Castillo Z, Guerrero F, Espino M, Austin KL. Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients. Contraception56(5), 313–316 (1997).
   PubMed Web of Science ®Google Scholar
• Prilepskaya VN, Serov VN, Zharov EV et al. Effects of a phasic oral contraceptive containing desogestrel on facial seborrhea and acne. Contraception68(4), 239–245 (2003).
   PubMed Web of Science ®Google Scholar
• Davis AR, Westhoff C, O’Connell K, Gallagher N. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. Obstet. Gynecol.106(1), 97–104 (2005).
   PubMed Web of Science ®Google Scholar
• Carr BR, DelConte A. Using a low-dose contraceptive in women 35 years of age and over: 20 microg estradiol/100 microg levonorgestrel. Contraception65(6), 397–402 (2002).
   PubMedGoogle Scholar
• Wei S, Venn A, Ding C, Foley S, Laslett L, Jones G. The association between oral contraceptive use, bone mineral density and fractures in women aged 50–80 years. Contraception (2011) (In Press).
   PubMedGoogle Scholar
• Coffee AL, Kuehl TJ, Willis S, Sulak PJ. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen. Am. J. Obstet. Gynecol.195(5), 1311–1319 (2006).
   Google Scholar
• Edelman AB, Gallo MF, Jensen JT, Nichols MD, Schulz KF, Grimes DA. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst. Rev.3, CD004695 (2005).
   Google Scholar
• Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasin R, Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil. Steril.80(3), 560–563 (2003).
   PubMed Web of Science ®Google Scholar
• Castaneda X, Garcia C, Langer A. Ethnography of fertility and menstruation in rural Mexico. Soc. Sci. Med.42(1), 133–140 (1996).
   PubMed Web of Science ®Google Scholar
• Boyle JS, Gramling LF, Voda AM. Eskimo women and a menstrual cycle study: some ethnographic notes. Health Care Women Int.17(4), 331–342 (1996).
   PubMedGoogle Scholar
• Kridli SA. Health beliefs and practices among Arab women. MCN Am. J. Matern. Child Nurs.27(3), 178–182 (2002).
   PubMedGoogle Scholar
• Forrest JD, Frost JJ. The family planning attitudes and experiences of low-income women. Fam. Plann. Perspect.28(6), 246–255, 277 (1996).
   PubMedGoogle Scholar
• Dominguez CE. Patient counseling women using oral contraceptives. Manag. Care Interface20(6), 33–37 (2007).
   PubMedGoogle Scholar
• Levinson RA. Reproductive and contraceptive knowledge, contraceptive self-efficacy, and contraceptive behavior among teenage women. Adolescence30(117), 65–85 (1995).
   PubMedGoogle Scholar